Multiscale Analysis of Intensive Longitudinal Biomedical Signals and its Clinical Applications by Nakamura, Toru et al.
  
 
To link to this article : DOI : 10.1109/JPROC.2015.2491979 
URL : http://dx.doi.org/10.1109/JPROC.2015.2491979 
To cite this version : Nakamura, Toru and Kiyono, Ken and Wendt, Herwig 
and Abry, Patrice and Yamamoto, Yoshiharu Multiscale Analysis of Intensive 
Longitudinal Biomedical Signals and its Clinical Applications. (2016) 
Proceedings of the IEEE, vol. 104 (n° 2). pp. 242-261. ISSN 0018-9219 
Open Archive TOULOUSE Archive Ouverte (OATAO)  
OATAO is an open access repository that collects the work of Toulouse researchers and 
makes it freely available over the web where possible.  
This is an author-deposited version published in : http://oatao.univ-toulouse.fr/ 
Eprints ID : 17027 
Any correspondence concerning this service should be sent to the repository 
administrator: staff-oatao@listes-diff.inp-toulouse.fr 
Multiscale Analysis of Intensive
Longitudinal Biomedical
Signals and Its Clinical
Applications
Recent advances in wearable and/or biomedical sensing technologies have made it
possible to record continuous biomedical signals over long periods of time. This
paper reviews multiscale approaches for their analysis.
By Toru Nakamura, Ken Kiyono, Herwig Wendt, Patrice Abry, Fellow IEEE, and
Yoshiharu Yamamoto
ABSTRACT | Recent advances in wearable and/or biomedical
sensing technologies have made it possible to record very
long-term, continuous biomedical signals, referred to as bio-
medical intensive longitudinal data (ILD). To link ILD to clini-
cal applications, such as personalized healthcare and disease
prevention, the development of robust and reliable data anal-
ysis techniques is considered important. In this review, we in-
troduce multiscale analysis methods for and the applications
to two types of intensive longitudinal biomedical signals,
heart rate variability (HRV) and spontaneous physical activity
(SPA) time series. It has been shown that these ILD have ro-
bust characteristics unique to various multiscale complex sys-
tems, and some parameters characterizing the multiscale
complexity are in fact altered in pathological states, showing
potential usability as a new type of ambient diagnostic and/
or prognostic tools. For example, parameters characterizing
increased intermittency of HRV are found to be potentially
useful in detecting abnormality in the state of the autonomic
nervous system, in particular the sympathetic hyperactivity,
and intermittency parameters of SPA might also be useful in
evaluating symptoms of psychiatric patients with depressive
as well as manic episodes, all in the daily settings. Therefore,
multiscale analysis might be a useful tool to extract informa-
tion on clinical events occurring at multiple time scales dur-
ing daily life and the underlying physiological control
mechanisms from biomedical ILD.
KEYWORDS | Autonomic nervous system; complex biosignals;
dynamical disease; heart failure; heart rate variability; multi-
scale fluctuations; psychiatric disorder; spontaneous physical
activity
I . INTRODUCTION
Ambulatory assessments have recently started to become
rapidly pervasive on a global scale. The development of
such technologies allows us to obtain large-scale data by
longitudinal recording of biomedical signals, such as
heart rate and physical activity time series. For instance,
in the last few years, a number of wearable devices and
cloud services using them for healthcare management
have been released at low cost [5]–[7]. However,
methods to analyze this kind of data collected continu-
ously in daily life, or so-called intensive longitudinal data
(ILD) [9], have not yet been fully established. To gain
useful information for better healthcare uses, it is impor-
tant to characterize signal features related to underlying
(Corresponding author: Y. Yamamoto.)
T. Nakamura and Y. Yamamoto are with the Graduate School of Education, The
University of Tokyo, Tokyo 113-0033, Japan (e-mail: yamamoto@p.u-tokyo.ac.jp).
K. Kiyono is with the Graduate School of Engineering Science, Osaka University,
Osaka 560-8531, Japan.
H. Wendt is with CNRS at IRIT, University of Toulouse, 3100 Toulouse, France.
P. Abry is with CNRS at ENS de Lyon, Physics Department, 69007 Lyon, France.
physiological control mechanisms and clinical events oc-
curring on multiple time scales.
In this review, we introduce studies on statistical and
dynamical characterizations of signals called heart rate
variability (HRV) [13], a sequence of heart inter-beat in-
tervals measured by ambulatory electrocardiography, and
spontaneous physical activity (SPA), or sometimes called
locomotor activity, measured by acceleration sensors
built, for instance, into a wrist band/watch [14], [15]. Be-
cause the data collection for these signals is one of the
easiest modes of ambulatory monitoring, these data are
indeed two typical examples of ILD [9] that can be ob-
tained from time scales of seconds, minutes, hours, and
even days (or months in the case of SPA). These types of
data contain signal components due to changes in physio-
logical states and/or behavioral episodes (exercise, sleep,
eating, etc.) in daily life. In addition to these limited
number of within-day states and/or episodes, they also
contain an even greater amount of fluctuations around
changes in local means, known to show characteristics
unique to various multiscale complex systems. These
characteristics include long-range correlation [16], [17],
fractality [18]–[21], multifractality [22], non-Gaussian
[17], [23] and/or non-Poissonian [1], [2] behavior, and
intermittency [3], [4], [11], [23]–[25].
From a biomedical perspective, the massive existence
of signal components exhibiting such multiscale com-
plexity is considered important for two reasons. First, as
it is difficult for an individual to control her/his physio-
logical states and behavioral episodes over a number of
multiple time scales at the same time for a long period
of recording during daily life, these components are most
likely to be generated unconsciously without being af-
fected much by the specific life-styles of patients. Thus,
they are considered to provide robust measures reflecting
intrinsic characteristics of underlying physiological con-
trol mechanisms [26]. Notwithstanding this, these mea-
sures for multiscale complexity have been shown to be
altered in pathological states: e.g., myocardial infarction
[27], [28] and heart failure [11], [23]–[25], [29] for
HRV, and major depressive disorder [1], [2], [30] and
schizophrenia [31] for SPA. Second, and more intrigu-
ingly, it may be possible that statistical as well as dynam-
ical features of these components (fluctuations) could
provide information about early signs of abrupt changes
in the state of the system [32], and in this case health
and medical status.
The importance of studying statistical and dynamical
features of fluctuations can be understood by using a
schematic view of the dynamics of physiological regula-
tions and the transition to a “dynamical disease” [33],
[34] state [Fig. 1]. Traditionally, physiological regulations
have been explained using the concept of homeostasis
(i.e., stability through constancy), maintaining constancy
of a vital variable by sensing its deviation from a set point
and providing feedback to correct the error. Short-range
negative correlations of state variables are expected in
such a case. In 1988, Sterling and Eyer [35] extended this
concept to that of allostasis (i.e., stability through change)
to account for the ability to adapt successfully to the chal-
lenges of “daily life” by the brain’s mechanisms to main-
tain viability, emphasizing the extremely demanding and
complex biological imperative that “an organism must
vary all the parameters of its internal milieu and match
them appropriately to environmental demands.” In this
allostatic state, the spatiotemporal complexity of the
brain’s control systems may give rise to multiscale com-
plexity in the state variables, and it has indeed been
shown that both HRV [24] and SPA [1], [2], [31] exhibit
long-range correlation and intermittent dynamics only in
the daily life condition (not, e.g., during non-Rapid Eye
Movement sleep). While allostasis is necessary to make
physiological regulations during daily life, further activa-
tion of this state may bring a system to the critical transi-
tion point where the emergence of longer period
oscillation (e.g., critical slowing down [32]) and/or larger
deviations could be early signs of disease onset and/or ex-
acerbation. In this review, we will show some examples
for such a scenario including that increased intermittency
and appearance of larger non-Gaussian deviation of HRV,
due most likely to the sympathetic over-excitation, were
associated with increased mortality in severe heart failure
patients [25].
The above concept of dynamical disease [i.e., the
qualitative transition (bifurcation) to a diseased state
through changes in control parameters] is not new and
was indeed proposed almost a couple of decades ago
[33], [34]. While it is intuitively useful in disease fore-
casting, prevention and control, verification has been dif-
ficult because it requires large amount of data for the
state variables to gain quantitative insights into the dy-
namical state of the system; now it may be possible, by
Fig. 1. A current schematic view on the onset of (transition to)
dynamical disease and multiscale fluctuations in state space.
using biomedical ILD, to quantitatively study the dynami-
cal disease. Therefore, the purpose of this review is to
provide an overview of multiscale fluctuation analysis of
emerging biomedical ILD and its clinical applications.
Specifically, in Sections II and III, respectively for HRV
and SPA, we will introduce: 1) the physiological back-
ground, a brief history of research and unsolved prob-
lems; 2) characterizations of multiscale dynamics mainly
focusing on intermittent and non-Gaussian behaviors in
signals; and 3) examples of clinical applications and im-
plications provided through the analysis of multiscale
fluctuations. This will be followed by Section IV, which
summarizes the findings and discusses future directions.
Numerous multiscale analysis tools have so far been de-
veloped, mostly in the fields of statistical physics and
biosignal processing (cf., e.g., [36]–[40]). The present
contribution concentrates specifically on tools that focus
on a joint analysis of the intermittent and non-Gaussian
nature of data. Interested readers are referred to, e.g.,
[41] for a comprehensive review of multiscale analysis
tools and their clinical applications for HRV.
II . HEART RATE VARIABILITY
A. What is HRV and Why is it Important?
Normal heart contraction is initiated by electrical im-
pulses from the sinoatrial (SA) node acting as the natural
pacemaker of the heart. On an electrocardiogram, nor-
mal beating (called normal sinus rhythm) generates a
seemingly periodic and well-defined pattern [Fig. 2(a)].
However, closer examination reveals that the heartbeat
intervals fluctuate in a complex and irregular manner
even for a healthy individual at rest [Fig. 2(b)]. This
fluctuation is caused by that of the pacing rate of the SA
node modulated primarily as well as continuously by the
activity of sympathetic and/or parasympathetic (vagal)
nervous fibers via the autonomic nervous system (ANS)
[42]. Sympathetic stimulation exerts facilitatory effects
on the heart and increases heart rate, whereas parasym-
pathetic stimulation exerts inhibitory effects and de-
creases heart rate. In addition, the ANS has a broader
range of cardiovascular effects (e.g., on blood pressure),
generating much more dynamical and complex behaviors
in heart rate. Therefore, through the analysis of heart
rate fluctuations, called heart rate variability (HRV), it
is possible to evaluate various aspects of ANS function
[13], [43].
Clinically, an ambulatory electrocardiography device
called the Holter monitor, used for the diagnosis of ar-
rhythmias, is used to continuously monitor HRV usually
for 24 hours [44], and it has been reported that reduced
and/or abnormal HRV in cardiac patients is associated
with higher mortality during follow-up periods [45]–[47].
Hence, HRV characteristics are expected to serve as prog-
nostic as well as diagnostic markers of various cardiovas-
cular disorders. Heart rate in healthy subjects is well
controlled by parasympathetic function; higher parasym-
pathetic activity is known to result in slower heart rate
and increases in parasympatheticmarkers (see Section II-B)
of HRV. On the other hand, decreased parasympathetic
activity evaluated by higher heart rate and reduced HRV
is associated with increased risk of mortality in cardiac
patients, such as those after acute myocardial infarction
(AMI) [47].
More importantly, available epidemiological and
clinical data have shown that increased activity of the
sympathetic nervous system leads to an increase in car-
diovascular morbidity and mortality [48]. Accumulating
evidence has suggested that sympathetic hyperactivity is a
potential cause of fatal cardiovascular events, and pre-
sumably the major contributor to arrhythmic events [48].
Therefore, the noninvasive assessment of sympathetic ac-
tivity to the heart is of great importance. However, as
shown in Section II-B, currently most HRV markers are
considered to reflect primarily parasympathetic func-
tions, and there is no widely accepted and well tested
HRV index used as a marker of sympathetic nervous sys-
tem activity [49].
Fourier power spectral density estimation has been a
main tool in conventional HRV analysis [13]. The power
spectral density provides a full characterization of sto-
chastic processes only when they are stationarity and lin-
ear [50]. Notably, power spectral density does not
account for any departure of data from Gaussianity.
However, many real-world signals including HRV time
series cannot be fully characterized based on the assump-
tion of stationary Gaussian linear processes, and display
much more complex behavior. To quantify such nonlin-
ear features, concepts and analysis methods developed in
Fig. 2. Definition of R-R interval (RRI) and 24 hour heart rate
variability (HRV). In general HRV analysis, the R-peak in normal
sinus rhythm is assumed. (a) The R wave can be detected as a
sharp positive peak in the standard electrocardiogram (ECG), and
the RRI is defined as the duration between successive R-waves.
(b) 24 hour HRV (normal-to-normal R-R intervals) in a 31-yr-old
male subject.
statistical physics and nonlinear dynamics have been ap-
plied to HRV analysis [51]. The nonlinear indices which
have been proposed include scaling exponents character-
izing fractal and long-range correlation characteristics
[16], [52], multifractal properties [22], Poincare´ plot-
based indices [53], entropy measures [54]–[57], symbolic
pattern statistics [55], [58] and non-Gaussian properties
[23]. Some of these nonlinear indices are expected to
provide complementary information on HRV characteris-
tics contributing to better diagnosis and prognosis than
conventional time and frequency domain indices.
With regards to a dynamical disease perspective
[Fig. 1], the following aspects of the HRV dynamics
should be considered as important: (1) common dynami-
cal properties of HRV have been observed in healthy sub-
jects even in daily life, when the measurements are
performed, [23], [26], although these properties can de-
pend on age [59], [60]; (2) these properties arise from
endogenous HRV dynamics, not from behavioral and en-
vironmental factors [23], [26]; and (3) an alteration of
such properties are associated with morbidity and mortal-
ity in cardiac patients [25], [28], [61], [62]. These proper-
ties have been observed in long-range correlation [26],
multifractality [22] and scale invariant non-Gaussianity
[23]. These characteristics are evaluated based on multi-
scale (or multiresolution) analysis, and have been exam-
ined as mortality risk markers for cardiac patients.
Moreover, some markers are suggested to be associated
with overall sympathetic hyperactivity during daily life.
Thus, multiscale analysis approaches could provide new
insight into HRV dynamics.
In this section, we discuss multiscale characteristics
of HRV and the key issues for evaluation of ANS func-
tions, especially sympathetic activity thought to play an
important role in the transition of the allostatic state.
B. Frequency Domain HRV Markers and the
Limitations
Frequency domain analysis based on Fourier power
spectral density estimation is a widely used tool for the
investigation of HRV [13]. HRV power spectral density
serves to detect a number of physiological processes
working at different and multiple time scales. In healthy
subjects under controlled conditions, a typical power
spectrum of HRV is comprised of two oscillating compo-
nents in high-frequency (HF; 0.15 to 0.4 Hz) and low-
frequency (LF; 0.04 to 0.15 Hz) bands [Fig. 3(b)], and a
1=f noise-like component in very-low-frequency (VLF;
below 0.04 Hz) band. The HF component reflects effects
of respiration on heart rate, referred to as respiratory si-
nus arrhythmia (RSA) while the LF component, associ-
ated with so-called Mayer waves (approximately 0.1 Hz),
represents oscillations related to regulation of blood
pressure and vasomotor tone. The origin of the VLF com-
ponent remains an open issue: it is however commonly
thought to relate to hemodynamic functions [13], [43],
[63], [64], such as thermoregulation and kidney func-
tion. For the noninvasive assessment of ANS functions,
power of the HF component is taken as a marker for car-
diac parasympathetic activity; the LF component is a
marker for cardiac sympathetic activity, or both the sym-
pathetic and parasympathetic influences, and the ratio of
LF to HF power (LF/HF ratio) indicates sympathovagal
balance, which is usually interpreted as reflecting the
relative sympathetic predominance [13], [65]. In this
view, an increase in LF power is assumed to indicate an
increase in sympathetic activity, and a higher value of
LF/HF ratio indicates a shift of sympathovagal balance
toward sympathetic predominance.
It is generally accepted that HF power reflects RSA me-
diated by the parasympathetic activity [66]. However, the
origin and clinical significance of LF power have aroused
considerable controversy. In short-term HRV recordings
(! minutes) under experimental conditions affecting
Fig. 3. Frequency domain HRV analysis. (a) Time series of R-R
intervals in a 31-yr-old male subject (top) and its frequency band
components (3 bottom rows). The time series was resampled at
evenly spaced intervals (2 Hz). The R-R time series was
decomposed into high frequency (HF: 0.15 to 0.40 Hz), low
frequency (LF: 0.04 to 0.15 Hz) and very low frequency (0 to
0.04 Hz) components. These components were obtained using the
inverse Fourier transform of corresponding frequency
components. (b) Power spectral density of the R-R time series (a).
(c) Assessment of the scaling exponent " of 24-h HRV. The power
spectrum was estimated from the resampled time series at 2 Hz.
autonomic response, the relative power contribution of LF
component is considered as a marker for sympathetic mod-
ulation [65], [67]. However, many studies using pharmaco-
logical, physiological and psychological manipulations
affecting sympathetic activity on HRV have challenged the
association of cardiac sympathetic activity with LF power
[68], [69]. The available data have suggested that over a
wide frequency range including HF and LF bands, the
HRV power spectrum is mainly determined by the para-
sympathetic system [70]. It has also been suggested that
the LF power constitutes an index of baroreceptor reflex
gain (or sensitivity) in mediating oscillations in blood pres-
sure and vasomotor activity [71], [72].
More controversial was the interpretation of LF
power and LF/HF ratio obtained from 24-hour ambula-
tory HRV recordings in patients with a marked reduction
in ventricular function. While in these patients, sympa-
thetic activity was reported to be markedly elevated [48],
a decrease in LF power and LF/HF ratio is more com-
monly observed, and associated with increased risk of
mortality [18], [73]. Therefore, clinical significance of as-
sociation of cardiac sympathetic activity with LF power-
related indices is questionable.
In addition to scale-specific behavior of HRV observed
in HF and LF bands, it has also been proposed that HRV
fluctuations show fractal, or scaling properties in the VLF
band (G 0.04 Hz), related to long-range correlations [16],
[17], [20], [59], [74], [75]. A time series is said to exhibit
long-range correlations when the data points across
widely separated times are correlated and the autocorre-
lation function of the time series or its increments shows
a power-law decay: Cð#Þ ! #$$ , where # is the time lag
[76]. Although the general mathematical mechanism for
generating long-range correlations is not clear, in some
numerical studies of complex systems, long-range correla-
tions emerge as a result of the collective behavior of mul-
tiple interacting components, each with its own, specific
and different characteristic time scales [77].
The conventional way to quantify long-range correla-
tions is to use power spectral analysis. Although long-
range correlated processes with SðfÞ ! f$" power spectra
have no characteristic time scale, such processes can be
characterized by a scaling exponent " [Fig. 3(c)]. The
1=f" power spectrum over large time scales is related to
the power-law autocorrelation ð! #$$Þ by " ¼ 1$ $
when 0G $ G 1 [78]. By estimating the slope in a log-log
plot of the 1=f"-type power spectrum, the scaling expo-
nent " can be obtained. A representative stochastic pro-
cess exhibiting monofractal behavior is fractional
Brownian motion (fBm) as a generalization of Brownian
motion [79]. This process is a Gaussian process BHðtÞ
and self-similar in terms of statistical properties:
BHðatÞ ¼! jajHBHðtÞ, where “¼!” denotes equality of the
probability distribution, 0 GH G 1 is a scaling exponent,
called the Hurst exponent, and related to " by
" ¼ 2H þ 1. In addition, the increment process of fBm
exhibits long-range correlation and is referred to as frac-
tional Gaussian noise (fGn), with " ¼ 2H $ 1.
In HRV analysis of healthy individuals, the value of "
is close to one in young adults, and gradually increases
with aging [59]. Moreover, an abnormal increase of "
(9 1.5) has been reported to be associated with an in-
creased risk of mortality in cardiac patients [61], [62]. To
consider this phenomenon, it is important to note that
the long-range correlated nature over the range of several
tens of seconds to a few hours arises from endogenous
HRV dynamics, not from exogenous effects such as be-
havioral and environmental factors [26]. To explain the
mechanism of the long-range correlated HRV, analogies
with critical phenomena have been proposed [23], [24].
The characteristic features at the critical point of a phase
transition are the divergence of relaxation time with
strongly correlated fluctuations and the scale invariance
in statistical properties. A healthy human heart rate has
been confirmed robustly to show the 1=f"-type power
spectrum. In addition, it is also reported that HRV in
healthy individuals undergoes a phase-transition-like be-
havior [24]. That is, highly correlated fluctuations are ob-
served only during daily activity, and a breakdown of
these characteristics occurs during prolonged, strenuous
exercise and in the nocturnal sleep period.
In the scaling analysis of HRV, it is important to note
that power spectrum analysis may provide spurious de-
tection of scaling properties caused by nonstationarity of
the time series [76]. The nonstationarity, such as a
smooth baseline trend and heterogeneous statistical
property, is known to introduce spurious scaling. To
avoid such artifacts and to provide more accurate esti-
mates of scaling exponents, alternative analysis methods
have been developed, such as detrended fluctuation anal-
ysis (DFA) [16] and multiresolution time-frequency anal-
ysis based on wavelet transform [80], [81]. In clinically
oriented studies, the DFA has been frequently used, and
some studies demonstrated its clinical significance (see
[41] for a comprehensive review). On the other hand,
multiresolution time-frequency analysis based on wavelet
transform has also been recognized as a tool to study
non-stationary signals [80], [81]. In this analysis, a time
series is decomposed into different time-scale compo-
nents. An advantage of wavelet analysis is that it can
have a salutary effect called vanishing moments which
eliminates smooth trends in the observed time series.
Wavelet analysis can provide more detailed information
about the time-varying properties of HRV. Therefore, it
may be a useful tool to detect and predict fatal events.
The ability of wavelet analysis to model and describe the
scale-free properties of HRV temporal dynamics has
been well documented in [23], [82]–[85].
C. Intermittent Fluctuations of HRV
In addition to 1=f" scaling as observed in fBm and
fGn, multiscaling (multifractal) properties of HRV have
been studied mainly in the field of statistical physics
[22], [82], [86]–[88]. Ivanov et al. reported, for the first
time, multifractality of HRV in normal subjects and re-
duced multifractality in patients with congestive heart
failure (CHF) [22]. Further, it has been suggested that
multifractal HRV is associated with ANS functions and
mainly with parasympathetic modulation [89], [90]. Re-
cent methodological developments in multifractal analy-
sis are expected to expand its potential applications to
HRV analysis [83]–[85], [91], [92].
Multifractal analysis was initially introduced to study
the so-called intermittency phenomenon of the fluid ve-
locity field in fully developed turbulence [93]. The multi-
fractality of the intermittent turbulent behavior is closely
related to a multiplicative cascade process where the lo-
cal energy on a given scale is linked to local energy on a
larger scale via a random multiplier [94], [95]. The ob-
served multifractality of HRV implies the intermittent
nature of HRV fluctuations and is analogous to the multi-
plicative cascade process [96].
A one-dimensional discrete time series based on the
idea of the multiplicative cascade can be constructed as
follows [97]: one starts with a discrete time series of
Gaussian noise fXtg of length 2m where m is the total
number of cascade steps, and split the interval into two
equal subintervals. On each subinterval, the local stan-
dard deviation (SD) is multiplied by random weights eY ,
where Y are independent Gaussian random variables
with variance %2=m and % * 0 is a shape parameter con-
trolling the strength of non-Gaussianity. Each of the two
subintervals is again cut in two equal subintervals and
the process is repeated. After m cascade steps, the time
series fbtg is given by








where b,c is the floor function. As shown in Fig. 4(a),
this process exhibits intermittent bursts due to the multi-
plication of multiple random variables. One of the main
tools to characterize these intermittent fluctuations has
been multifractal analysis [e.g., Fig. 4(c)]. On the other
hand, a remarkable property of the intermittent fluctua-
tions is heterogeneity of variance, which results in non-
Gaussian probability density functions (PDF’s) [Fig. 4(b)].
Thus, characterization of intermittent fluctuations is pos-
sible through the analysis of the deformation process of
Fig. 4. Characterization of intermittent fluctuations. (a) An example of an intermittent time series fbtg generated by a multiplicative
cascade model (Eq. (1) with %2 ¼ 0:82, m ¼ 16). (b) Deformation of PDF’s of f!sBðtÞg, where BðtÞ ¼
Pt
k¼1 bðkÞ and !sBðtÞ ¼ Bðtþ sÞ $ BðtÞ.
Standardized PDF’s for different scales are shown for (from top to bottom) s ¼ 1; 4; 16. In the solid lines, we superimposed the PDF’s
approximated by a multiplicative log-normal model [Eq. (3) with a Gaussian kernel G]. For comparison, the dashed lines denote a
Gaussian distribution. (c) The singularity spectrum DðhÞ of the integrated series fBðtÞg. DðhÞ was estimated from 64 samples using
p-exponent and p-leader based multifractal analysis with p ¼ 1 (see [8] for details). (d) Scale dependence of %2 of f!sBðtÞg. Dashed lines
indicate theoretical predictions: %2s ¼ %2ð1$ log2 s=mÞ [10]. Error bars indicate standard deviations.
the non-Gaussian PDF’s across scales [Fig. 4(d)] [10],
[97], [98]. Recently, the non-Gaussianity of HRV has
been suggested as a marker potentially related to sympa-
thetic cardiac overdrive [11], [25], [28]. Therefore, per-
haps even more so than conventional HRV markers
associated mainly with parasympathetic activity, this ap-
proach may be useful to evaluate another important phys-
iological function. In addition, long-range correlation,
multifractality, and large non-Gaussian deviations are
commonly observed near dynamical transition points
[99], [100] [Fig. 1]. Therefore, such properties may be
useful for finding early warning signals for fatal and cata-
strophic events.
1) Multifractal Analysis—HRV as Multiplicative Cascades:
Multifractal analysis is able to characterize the fluctua-
tions over time of the (ir-)regularity or singularity of a
signal XðtÞ, measured by a pointwise regularity (Ho¨lder)
exponent hðtÞ, by means of the so-called singularity spec-
trum, defined as the fractal (Hausdorff) dimension of the
set of time instances with the same regularity [101]:
DðhÞ ¼ dimH tijhðtiÞ ¼ h
% &
: (2)
The practical counterpart enabling the estimation of
DðhÞ from data termed multifractal formalism relies on
the characterization of scaling behavior of higher order
statistics.
Many methods have been proposed to estimate the
singularity spectrum DðhÞ from observed time series (cf.
[84] for a review). As for the multifractality of HRV,
wavelet transform modulus maxima (WTMM) methods
[38] and multifractal detrended fluctuation analysis
(MFDFA) [39], [40] have been mainly employed [22],
[82], [86], [87], [89], [90].
Most recently, a framework has been proposed that
extends the wavelet based analysis of self-similar pro-
cesses and the estimation of the Hurst parameter H to
the analysis of multifractal scaling and to the estimation
of the multifractal spectrum DðhÞ [8]. It is referred to as
p-exponent and p-leader based multifractal analysis, and
it permits, beyond the limitation of the Ho¨lder exponent
(*0), accounting for negative regularity, widely ob-
served in the real-world time series and notably in HRV.
Thus, this approach could provide a new and powerful
tool to examine the multifractality of HRV, as shown in
Fig. 6(d).
Matlab code implementing the wavelet analysis of
self-similarity and multifractality is available at http://
www.irit.fr/~Herwig.Wendt/software.html#wlbmf.
2) Non-Gaussian Properties of HRV: In studies of devel-
oped turbulence and non-equilibrium systems exhibiting
intermittent fluctuations, it has been demonstrated that
the observed non-Gaussian probability distributions with
fat tails are often described effectively by a superposition
of Gaussian distributions with fluctuating variances
[102]. Based on this framework, the observed distribu-











where PL is the standard Gaussian distribution and G is a
distribution describing the fluctuation of the standard de-
viations. In the analysis of intermittent fluctuations, we
focus mainly on the estimation of the variance of G and
its scale dependence [102].
Based on this framework, Kiyono et al. proposed a
multiscale probability density function (PDF) analysis in-
cluding a detrending procedure [23], [98]. The proce-
dure of this analysis is as follows: (1) Time series of R-R
intervals are interpolated and resampled at 4 Hz, yielding
interpolated time series fbtg. After subtracting the mean
from the interpolated time series, integrated time series
fBðtÞg are obtained by integrating fbðtÞg over the entire
series length. (2) The integrated time series fBðtÞg are
divided into overlapping segments of length 2s with
50% overlap, where s is the scale of coarse graining
(s ¼ 25 sec in Fig. 5). In each segment, the local trend
is eliminated by third-order polynomial fit. (3) Coarse
grained variation !sBðtÞ is measured as the increment
with a time lag s of integrated and detrended time se-
ries. (4) f!sBðtÞg is standardized by its standard devia-
tion to quantify the PDF. Then, the non-Gaussianity
























where EðXÞ is the expectation value of X and " is the
Gamma function [97]. In previous studies [25], [28], %s
is estimated based on the 0.25th-order moment ðq ¼
0:25Þ to emphasize the center part of PDF. In this anal-
ysis, the observed non-Gaussian shape [Fig. 4(b)] at
each scale is quantified by the non-Gaussianity index %s
defined as the standard deviation of ln( in (3), where
G is assumed to be a Gaussian. The greater the %s, the
greater the proportion of large deviation than what is
expected from the Gaussian distribution.
Using this method, Kiyono et al. reported robust
scale-invariant properties in non-Gaussian distributions
observed in healthy human HRV spanning the range of
about 20–2000 beats, which were preserved not only in
a quiescent condition, but also in a dynamic state where
the mean level of the heart rate was dramatically chang-
ing [23]. In addition, in patients with CHF, increased
non-Gaussianity at scale of 40 beats of 24-hour ambula-
tory HRV predicts increased mortality risk, while none
of the conventional HRV indices, including those reflect-
ing vagal heart rate control, were predictive of death
[25]. Moreover, Hayano et al. reported that, in patients
after AMI, an increased non-Gaussianity index %25 sec at
a scale of 25 sec is associated with increased cardiac
mortality risk, and its predictive power is independent of
clinical risk factors and of other HRV predictors [28].
The aspects characterized by %25 sec are related to am-
plitude modulation properties of LF component as shown
in Fig. 3(a). The detrending procedure in multiscale PDF
Fig. 5. Representative examples of non-Gaussian heart rate fluctuations during the daytime in a healthy subject and a congestive
heart failure patient. Time series of normal-to-normal R-R intervals (top row), standardized time series of coarse grained heart rate
variations f!25 secBðtÞg (middle row), and standardized PDFs of !25 secBðtÞ (bottom row). Estimated values of the non-Gaussianity index
%25 sec are shown in each panel in the bottom row. The solid lines represent the PDF approximated by a multiplicative log-normal
model [(3) with a Gaussian kernel G].
Fig. 6. Scale dependence of the non-Gaussianity index %2s and Multifractal spectrum DðhÞ of daytime HRV (12:00-1800). The result for:
(a) congestive heart failure (CHF) patients, both for survivors ðn ¼ 69Þ and non-survivors ðn ¼ 39Þ within the follow-up period of
33 0 7 months; (b) multiple system atrophy (MSA); and (c) Parkinson disease (PD) patients. Age-matched controls were selected from
a database of healthy subjects. Error bars indicate 95%-confidence intervals of the group means. The gray shaded range corresponds
to low-frequency band ðsG25 secÞ. Marked increases in %2s in the gray shaded scales are observed only in CHF patients, particularly
non-survivors (a). DðhÞ are estimated in the range of 10–200 sec using p-exponent and p-leader based multifractal analysis with p ¼ 1
(see [8] for details). These figures are modified versions from [11].
analysis acts as a high-pass filter that removes low fre-
quency components below a given time scale, and the
calculation of partial sums (or increments of integrated
series) acts as a low-pass filter. In the estimation of
%25 sec, the combination of these procedures acts as a
band-pass filter that allows mainly the LF component to
pass. The increased %25 sec indicates an increase in ampli-
tude heterogeneity of LF oscillation as seen in Fig. 5
(middle rows). Note that the %25 sec can change indepen-
dently of the value of LF power. Thus, the %25 sec can
provide complementary information beyond conventional
frequency domain indices.
As for the association of %25 sec with the ANS func-
tions, the following facts should be considered: (1) The
HRV in the scales corresponding to HF and LF bands are
mediated almost exclusively by neural autonomic mecha-
nisms [13], [103]. (2) The %25 sec showed no substantial
correlation with the HRV indices reflecting vagal heart
rate regulation [25], [28]. (3) %25 sec was decreased in post-
AMI patients taking beta-blockers suppressing the sympa-
thetic influence [28]. Based on these facts, Hayano et al.
suggested that %25 sec captures heart rate fluctuation at
least partly mediated by intermittent activations of cardiac
sympathetic activity [28].
In addition, in the study of daytime HRV in patients
with multiple system atrophy (MSA) and with Parkinson
disease (PD), it is reported that a marked increase in
non-Gaussianity on a relatively short time scale observed
in CHF patients was not observed in these patients with
sympathetic dysfunction [11]. Both MSA and PD are pro-
gressive neurodegenerative disorders, although auto-
nomic lesions in MSA are caused by preganglionic
sympathetic failure [104], and those of PD are ganglionic
and postganglionic [105], [106]. As shown in Fig. 6, com-
pared with an age-matched healthy control group, mean
values of %s in CHF patients, especially nonsurvivors in
comparison to survivors during the follow-up period, dis-
play marked increases in relatively small scales covering
the LF band. On the other hand, as shown in Fig. 6(b)
and (c), such marked increases were not observed in
MSA and PD patients. This result also supports the view
that an increase of %25 sec could be a hallmark of overall
cardiac sympathetic overdrive detectable with ambulatory
HRV monitoring.
The fact that heart rate dynamics of CHF patients
with elevated sympathetic activity exhibit a marked in-
crease in non-Gaussianity and its decays with scales
within LF and VLF ranges suggests a sympathetic origin
for HRV intermittency. In these scales (G 200 sec), heart
rate dynamics reflect cardiovascular regulation by neural,
humoral, and thermal influences [107]. These subsystems
are considered to be compensatory; therefore, it is likely
that only simultaneous failure of all these subsystems op-
erating on multiple time scales, compatible with the re-
ciprocal of cascade steps “j” in (1) could result in
sympathetic overdrive, leading to intermittent heart rate
fluctuations with large deviations. We propose that such
a multiplicative picture would provide a deeper physio-
logical understanding of the nature of sympathetic func-
tion [11]. As shown in Fig. 6(d), intermittent nature of
HRV in CHF patients may also be characterized by mul-
tifractal analysis. Also, the fact that HRV of non-surviving
CHF patients exhibit stronger LF intermittency than that
of surviving patients [Fig. 6(a)] would indicate a relation-
ship between appearance of the HRV intermittency (due
to sympathetic overdrive as a control parameter) and a
pathological transition [Fig. 1]. The same scenario also
applies to AMI patients in [28].
D. Remarks and Other Methods
Sympathetic nervous system activity is thought to be
an important factor in many health problems, not only
in cardiovascular diseases but also in the development of
a wide variety of chronic illnesses [108]. Therefore, mul-
tiscale analysis characterizing the intermittent nature of
HRV may have widespread applications in various fields
of health management. Among HRV indices that have
been suggested as markers of sympathetic activity, an in-
creased non-Gaussianity of HRV may reflect hazardous
effects of elevated cardiac sympathetic activity in cardiac
patients. In addition, some other nonlinear markers not
mentioned in this paper, such as approximate and sample
entropies, have been suggested to be associated with
sympathetic activation [109], [110]. Moreover, multiscale
entropy analysis [36], [37] and other multiscale tools,
such as empirical mode decomposition [111] may have
potential clinical applications. However, to establish as-
sociations between sympathetic activity and the clinical
significance of these approaches, systematic validation
and further studies on a large scale data are yet required.
III . SPONTANEOUS PHYSICAL
ACTIVITY
A. Alterations of SPA in Psychiatric Diseases
In the fields of psychiatry and mental healthcare, pre-
vention and early intervention are crucially important
and widely accepted as effective strategies to reduce the
number of patients with serious psychiatric disorders and
ultimately medical/healthcare related costs [112]–[114].
In order to develop a reliable and effective strategy based
on clinical evidence, the identification of an objective
biomarker for psychiatric disorders is essential because it
could contribute to the early detection of warning signs
for pathogenic and/or pathological changes resulting in
the development of these illnesses [115]. However, such
an objective measure has not been fully developed.
The recent development of information and commu-
nication technologies, such as wearable/mobile devices,
provides massive longitudinal, non-medical data from
our daily lives (e.g., physical activity, heart rate, GPS,
etc.), which are thought to include useful information on
our physiological and/or pathological conditions. While
the extraction of pathological information available for
clinical use is still challenging, many researchers have re-
cently studied and reported promising outcomes [116]–
[118]. In this section, we introduce examples of objective
evaluation of psychiatric disorders based on physical ac-
tivity easily assessed by using a wearable device.
1) Behavioral Abnormalities in Psychiatric Disorders:
Physical activity can be continuously monitored in a
quantitative and noninvasive way, e.g., through the use
of a wrist watch- type or band-type acceleration sensor, a
method referred to as actigraphy. This type of device has
the capability of detecting small changes in bodily/wrist
acceleration so that even slight movements by the sub-
jects are registered. Therefore, the data recorded include
information on both conscious and unconscious behav-
iors in daily life. In this review, we call this type of lon-
gitudinal behavioral data spontaneous physical activity
(SPA).
Behavioral alteration is one of the cardinal signs of
psychiatric disorders, and many psychiatric disorders, in-
cluding depression, indeed have diagnostic criteria which
require an assessment of altered physical activity [15].
For instance, one of the known disease signs of depres-
sion is psychomotor retardation, involving a recognizable
alteration in physical activity such as slowing down of
movement [119]. Therefore, behavioral dynamics is con-
sidered to contain rich information on pathological
symptoms of psychiatric disorders and is thought to be
useful for objective diagnosis of disorders.
In order to characterize behavioral abnormalities, in-
cluding chronobiological disturbances, basic statistics (e.g.,
mean and variance) and periodicities (by, e.g., cosinor
method or Fourier analysis) of SPA have been tradition-
ally evaluated. For example, reduced daily activity levels
have been reported in patients with major depressive dis-
order (MDD) [14], [15] and schizophrenia [120], [121].
On the other hand, increased activity levels were shown
in patients with attention-deficit hyperactivity disorder
[122], [123] and patients with bipolar disorder (BD) dur-
ing manic phases [124]. In addition, significant associa-
tions of these statistics with clinical variables have also
been confirmed [125]–[127]. From the viewpoint of dy-
namical properties of SPA, Hauge et al. examined an en-
tropy measure to show the increase in complexity of SPA
in schizophrenia [120]. Indic et al. examined the scaling
behavior of amplitudes of SPA on multiple time scales
and reported altered scaling behavior in BD as well as as-
sociations with clinical states, indicating the utility of
monitoring SPA for objective evaluation of pathological
states of BD [128].
The direct connection between alterations in these
traditional measures and the underlying pathophysiology
is unknown, but several studies using neuroimaging
approaches have recently suggested the existence of asso-
ciations of SPA with brain structures or functions in the
motor control systems [129]–[132]. For example, altered
associations of SPA with structures and functions of mo-
tor regions of brain, including anterior cingulate cortex,
supplementary motor area, and thalamus, have been re-
ported in schizophrenia patients [129], [131], [133]. In
addition, a relationship between dysfunction of cortico-
basal ganglia pathways in white matter and the patho-
physiology of hypokinesia in schizophrenia has been
reported, suggesting that structural disconnectivity could
lead to disturbed motor behavior in schizophrenia [132].
Studies about MDD have also demonstrated the link be-
tween psychomotor retardation and white matter integ-
rity of the motor system [134], [135]. These reports
manifest the existence of underlying neurological bases
for SPA.
B. On-off Intermittency and Scale-Invariance in SPA
As detailed in this subsection, Nakamura et al. re-
cently studied the dynamical properties of SPA and dis-
covered robust statistical laws of behavioral organization,
specifically how resting and active periods derived from
physical activity data are interwoven into daily life [1],
[2], [31]. Furthermore, they reported alterations in the
resting period statistical law in patients with MDD [1]
and schizophrenia [31] reflecting increased intermittent
bursts in activity counts characterized by reduced activity
levels associated with occasional bursts of physical activ-
ity. These studies manifest that the quantitative and ob-
jective evaluation of intermittency of physical activity
could provide appropriate behavioral measures capable of
probing alterations in pathological states in psychiatric
disorders.
1) Intermittent Nature of SPA and its Alterations: Fig. 7
shows typical fluctuations of SPA in a healthy subject
and in a patient with MDD. In the healthy subject
[Fig. 7(a)], a clear circadian rest-activity cycle is observed,
while in the MDD patient [Fig. 7(b)], this rhythmic pat-
tern is notably disrupted, reflecting the reported chrono-
biological abnormality in depression [14]. During the
daytime, physical activity of the healthy subject is charac-
terized by consistently higher activity levels, whereas the
MDD patient exhibits intermittent bursts in activity
counts with more episodes of slowing down or cessation
of movements [1], [31]. As mentioned below, the inter-
mittent burst is a significant dynamical feature of physical
activity and its alteration is a robust and effective indica-
tor for behavioral abnormalities observed in psychiatric
disorders.
2) Statistical Laws of Behavioral Organization: In order to
characterize the intermittent patterns in physical activity,
Nakamura et al. evaluated the cumulative probability dis-
tribution PCðx * aÞ of durations a of both resting pe-
riods, where the activity counts were successively lower
than a certain predefined threshold value (e.g., an over-
all average of non-zero activity counts), and of active
periods, where the counts were successively higher
than the threshold values [1], [2] [the bottom panels in
Fig. 7(a) and (b)]. The robust statistical laws they found
in healthy subjects [1], [2], against factors such as differ-
ence in study populations and choice of different thresh-
olds, were the power-law distribution PCðx * aÞ ! a$$
with the scaling exponent $ ! 1:0 for the distributions of
resting period durations [Fig. 7(c)] and the stretched ex-
ponential functional form PCðx * aÞ ¼ expð$*a"Þ with
the stretching parameter " ! 0:5 for the distribution of
active period durations [Fig. 7(d)]. In addition, they re-
ported that these statistical laws found in healthy humans
were shared by wild-type mice (i.e., no significant differ-
ence in values of the scaling exponent $ and the stretch-
ing parameter "), suggestive of the presence of an
underlying principle governing behavioral organization, or
behavioral switching, across species [2]. Furthermore, a
significant decrease in $ of resting period distributions
among humans with MDD or schizophrenia [1], [31] and
mice with deficiency in a circadian clock gene (Period 2)
[2] has also been reported. These findings indicate that al-
terations in intermittency of behavioral dynamics charac-
terized by $ are useful for describing abnormalities in SPA
observed in psychiatric disorders. Another important point
to be emphasized is the possibility that the cross-species
translation provided by the statisitcal law of behavioral
organization may play a crucial role in bridging the gap
between specific genetic substrates and behavioral endo-
phenotypes in psychiatric disorders [136], [137].
3) A Model for on-off Intermittency in Behavioral Organiza-
tion: In order to elucidate the underlying mechanisms of
the alteration in resting period distributions, a mathe-
matical model based on queuing theory [12], [124],
which models a decision-making strategy for selection of
Fig. 7. Fluctuations in spontaneous physical activity and their statistical laws of behavioral organization (modified from [1], [2]).
Illustrative examples of physical activity data for a healthy adult (a), and a patient with major depressive disorder (MDD) (b) over
three consecutive days (top panels). These data were measured by a watch-type device (Ambulatory Monitors Inc., Ardsley, NY, USA)
worn on the wrist of their non-dominant hand. The zero-crossing mode, which measures counts of events in which an acceleration
signal crosses a zero level within a predefined time (e.g., 1 min), is used. The middle panels are magnifications of the top panels with
4 h periods during the third day. The overall average of non-zero activity counts was used as the threshold (horizontal dotted line),
and the period during which the activity counts were successively below or above the threshold is defined as a resting or active
period, respectively (bottom panels). (c) Cumulative distributions PCðx * aÞ of resting period durations a for healthy adults (open
circles) and MDD patients (blue filled squares). Straight lines are eye guides with the overall mean values; the power law distribution
with $ ! 1:0 for healthy adults and $ ! 0:7 for MDD patients, respectively. The green curve indicates a random case (i.e., an exponential
functional form). (d) The same as (c) but for active period durations. The stretched exponential functions were nicely fitted to the
active distributions. Error bars indicate standard error of the mean.
a biological “cue” to response [4], was considered. This
model is based on the following assumptions; spontane-
ous movements in animals would be triggered by contin-
uously presented internal or external demands and/or
stimuli (e.g., appetite, emotion, etc.); on the basis of
their biological importance, one demand/stimuli is prob-
abilistically chosen either consciously or unconsciously.
This decision-making process can be modeled well by a
stochastic priority queuing model. In [4], we demon-
strated that a strategy where each demand/stimuli is
probabilistically chosen every time in proportion to its
biological importance can explain the unique statistical
law of resting periods with $ ! 1:0. Mathematically, with
the probability of response to a demand/stimuli with
priority x given by
QðxÞ ! x [black line in Fig. 8(a)],
the cumulative distribution of durations of resting pe-
riods is analytically derived to follow the power-law func-
tional form [12] with the exponent $ ¼ 1 [Fig. 8(b)]. In
contrast, the decrease of $ observed in MDD, schizo-
phrenia, and BD during the depression phase [Fig. 8(c);
see III-C below] can be reproduced by assuming
QðxÞ !
x% with % greater than unity (e.g., % ¼ 1:4) [blue curve
in Fig. 8(a)]. This assumption implies that a demand/
stimuli with higher priority is preferentially selected, giv-
ing rise to a fatter distribution tail and frequent episodes
of longer resting periods, generating a more intermittent
sequence of onset of activity bursts [Fig. 8(c)]. Also, the
increase of $, observed in a patient with BD during a
manic episode, can be modeled by assuming % smaller
than unity (e.g., % ¼ 0:8) [red curve in Fig. 8(a) and
(d)]. Based on the findings for mice with deficiency in
Period 2 also showing decreased $ [138], [139], we dis-
cussed [4] that these strategic changes in decision-making
—preferential selectivity to demands and/or stimuli with
higher priority—may be related to reinforcement of re-
warding neural networks induced by dysfunction of the
dopamine and/or glutamatergic systems.
C. Towards Monitoring and Early Detection of
Psychiatric Disorders
1) ILD of SPA in Bipolar Disorder: Bipolar disorder is a
major psychiatric disorder demonstrating recurrent and
alternating periods of manic (or hypomanic), depressive,
and mixed episodes, with varying intervals [119], [140],
[141]. Mania, a period of elevated or irritable mood, as
well as increased energy (overactivity) and a decreased
need for sleep, is the defining feature of BD. On the
other hand, like MDD, depressive episodes are character-
ized by lack of interest, loss of energy, insomnia, fatiga-
bility, and suicidal thoughts. The most prominent feature
Fig. 8. Sequences of resting period durations and their model (modified from [4]). (a) Probability density function
QðxÞ ! x% for
choosing a demand/stimulus with physiological priority x. The sequence of onset of activity bursts (resting durations) derived from
physical activity of a (b) healthy adult ð$ ! 1:0Þ, (c) a bipoloar disorder (BD) patient in the depressive phase ð$ ! 0:7Þ, and (d) in the
hypomanic phase. The sequence of waiting times simulated from the priority stochastic queuing model with (b) % ¼ 1:0 (i.e., $ ¼ 1:0),
(c) % ¼ 1:4 (i.e., $ ! 0:7), and (d) % ¼ 0:8 (i.e., $ ! 1:25) are also shown. The simulated sequences of waiting time were generated on the base
of the stochastic priority queuing model [12] with a priority list comprising L ¼ 10 demands, where a priority parameter xi ði ¼ 1; . . . ; LÞ
chosen from a uniform distribution +ðxÞ ¼ Uð0; 1Þ is assigned to each demand. At each time step, one demand is selected from the list
(in the brain) according to
QðxÞ ! x% for execution (or act), and then removed from the list. At that moment, a new demand is added to
the list with a priority randomly selected from +ðxÞ. The probability that a demand with priority x is executed at time t is given by
fðx; tÞ ¼ ð1$QðxÞÞt$1QðxÞ, and the average waiting time of a demand with priority x is obtained by averaging over t weighted with fðx; tÞ,
giving rise to #ðxÞ ¼P1t¼1 tfðt; xÞ ¼ 1=$ðxÞ 1 1=x%. Analytically, with the conservation law of probability ð+ðxÞdx ¼ Pð#Þd#Þ, the waiting time
distribution of the demands is given by Pð#Þ 1 +ð#$1=%Þ=#1þ1=%. Note that each vertical line separates the successive waiting time of demands
chosen according to their priority.
of BD is the switching dynamics between depressive and
manic phases. Elucidating the underlying mechanism of
these sudden changes in pathological states is important
as it would contribute to the precise and reliable predic-
tion of the timing of these transitions. This in turn
would lead to the development of timely and efficient
clinical interventions, and novel treatments aimed at the
prevention of suicide and decreasing the risk of issues
with social relationships, loss of job and financial prob-
lems. However, little attention has been given to these
sorts of dynamical features (clinical phase transitions) of
pathological states in BD.
A longitudinal study design allows us to investigate
dynamical aspects in pathological states during the period
of clinical phase transitions in BD, along with inter-
relationships between psychological and behavioral vari-
ables. Indeed, studies examining BD using longitudinal
designs have demonstrated dynamical changes related
with phase transitions in subjective mood [142], [143],
physical activity (including sleep and circadian rhythm)
[144], [145], and biochemical variables [146].
Nakamura et al. recently measured ILD of SPA and
self-reported symptoms in bipolar patients (type-II) to cap-
ture clinical phases transitions [3]. Fig. 9(a) and (b) repre-
sent an example of physical activity data and subjective
mood scores continuously monitored over almost one year,
respectively, including a period of well-identified clinical
phase transition. The activity levels during around 110–
140 days were consistently low with worsening of mood,
indicative of a depressive episode. After this period, the
mood scores gradually increased and then reached at the
maximum score (the patient rated the best) on day 165. In
parallel with this rapid mood change, the activity levels in-
creased, manifesting the transition from the depressive
phase to manic phase. The physical activity [labeled “A” in
Fig. 9(a)] during the depressive phase showed frequent in-
termittent bursts in the activity counts during the daytime
[Fig. 9(d)], while the data [labeled “B” in Fig. 9(a)] in the
manic phase was characterized by more sustained higher
activity levels [Fig. 9(e)] [3].
In this subsection, we demonstrate the possibility to
objectively monitor changes in pathological states based
on alterations of behavioral dynamics (i.e., intermit-
tency) and further discuss the detection of early signs for
clinical phase transition.
2) Objective and Continuous Monitoring of Pathological
States: Application of the method for behavioral organiza-
tion (see Fig. 7) during the clinical phase transition re-
vealed that the resting period distributions in both
depressive and hypomanic phases took a power-law form
PCðx * aÞ ! a$$ over almost two decades (from 2 min to
100 min), with considerable difference in their scaling
exponent [$ ¼ 0:85 for the data during depressive phase
shown in Fig. 9(d) and $ ¼ 1:22 for the data during hypo-
manic phase shown in Fig. 9(e)]. The increase in longer
resting periods in the depressive phase, like MDD,
suggests more episodes of slowing down or cessation of
movement in depressive phase than in hypomanic phase.
The continuous nature of physical activity data allows
us to evaluate daily changes in values of $ in a continu-
ous fashion [Fig. 9(c)]. The objective behavioral index $
can distinguish the differences in pathological states in
BD; the values of $ were lower in depressive phase than
those in hypomanic phase. In addition, the low-frequency
fluctuations (9 7 days) in the value of $ demonstrated the
significant concurrent association with self-reported
mood scores and the values of $ [3]. This indicates the
possibility of quantitatively and continuously capturing
manic-depressive phase transitions from physical activity
monitored using a wearable device.
3) Detection of Early Signs for Pathological Transitions
From the Viewpoint of Dynamical Systems: Investigation
into a theory for aperiodic alterations between depressive
and manic episodes, by developing a dynamical model,
may help elucidate the underlying mathematical mecha-
nisms of the pathological phase transitions in BD and de-
velop novel prediction methods, leading to timely and
effective interventions.
The most prominent dynamical feature of BD is the
coexistence of two extreme mood states (depression and
mania) and oscillating/switching dynamics between them
with unequal durations of each episode [143]. In addi-
tion, clinical observations suggest that this aperiodicity
in transition periods is determined by the interaction be-
tween the biological mechanisms generating periodicity
and environmental and psychological stresses in daily life
[144], [147]. These complex and nonlinear dynamical
phenomena are reminiscent of bistability. Although other
dynamical models could be considered to describe the al-
ternating phenomena between manic and depressive
states [143], we start from hypothesizing a bistable sys-
tem as a simple model to explain the switching mecha-
nism. Indeed, by proposing a mathematical model with
bistability, Goldberter successfully simulated the recur-
rent and alternating switching dynamics between depres-
sion and mania, together with the antidepressant effects
clinically observed [148] (e.g., a transition to mania or
rapid cycling triggered by antidepressants [149]).
Bifurcation of the bistable system reproduced the
phenomena clinically observed in patient with BD well.
If the same mechanism exists in actual pathological tran-
sitions, there is a possibility to detect a tipping point of
pathological transitions by evaluating the dynamical fea-
tures of fluctuations in physiological parameters (e.g.,
mood and/or physical activity) because the system dis-
plays complex and unique fluctuations around a bifurca-
tion point [32]. Fig. 10(a)–(c) shows potential landscapes
illustrating a bifurcation phenomenon of a bistable sys-
tem as a model for pathological cycling in BD. Under the
condition where a control parameter governing the dy-
namics of the system is sufficiently close to a bifurcation
point, the steady states (potential wells) become unstable,
and the system can no longer remain at these states, start-
ing to fluctuate in a unique manner [Fig. 10(b)]. There-
fore, the evaluation of dynamical features of fluctuations
in state variables allows us to detect a tipping point of
pathological transitions, like the dynamical disease sce-
nario in Fig. 1. For example, critical slowing down is
known as a characteristic dynamical phenomenon emerg-
ing in the vicinity of a phase transition or a critical point
[32], indicating the occurrence of bifurcation in the un-
derlying systems. These early warning signs are com-
monly observed in a variety of fields from economics to
climate systems [32], [150]–[153]. Systems showing
Fig. 9. Dynamics of spontaneous physical activity and subjective mood during clinical phase transitions in bipolar disorder (BD)
(modified from [3]). (a) A double-plot actogram of physical activity data of a patient with BD over 333 days. For presentation
purposes, the activity data were converted into resting and active periods and then color coded according to the corresponding value
of $ [see (c)]. (b) Fluctuations in subjective mood scores reported by the patient every night, ranging from the 0 (the worst) to 10 (the
best). The clinical phase transition from a depressive phase to a hypomanic phase occurred during the period between days 140–150.
(c) The continuous evaluation of the scaling exponent $ of resting period distributions. Here, the value of $ was continuously estimated
by using a sliding window of 7-day width by shifting 1 day [red filled circles in (c)]. The trend of $ [blue curve in (c)] significantly traced
pathological changes of depressive-manic cycles rated by subjective mood [3]. The physical activity data during depressive phase (d)
and manic phase (e), labeled “A” and “B” in the panel (a), respectively, are shown in (d) and (e). Their magnification with 4 h periods
during the third day is also shown. The value of $ was 0.85 and 1.22, respectively.
critical slowing down are theoretically characterized by a
decreasing rate of recovery from small perturbations
(slowness), which results in the accumulation and persis-
tence of perturbations over time, leading to increases in
local variance and autocorrelation around critical points
[32]. Fig. 10(e) as applied to the BD transition shows the
changes in autocorrelation coefficients obtained by fitting
an autoregressive model of order 1 [i.e., AR(1) model] to
the data of $ [shown in Fig. 10(d)] within a sliding win-
dow of size 10 days. During the transition period from de-
pressive to manic phase (from 130–150 days), the
autocorrelation coefficients of daily fluctuations of $
gradually increase, possibly giving rise to an early warn-
ing sign for the phase transition. On the other hand, dur-
ing clinically “stable” states in depressive and manic
phases, the decrease of correlation coefficients to around
zero value can be observed. This implies that the state of
the system randomly fluctuates around a stable well
[Fig. 10(a) or (c)]. This example suggests the possibility
of detecting early warning signs for pathological transi-
tions by evaluating the dynamical features of SPA, and
also the viability of utilizing biomedical ILD to empiri-
cally study disease dynamics, i.e., dynamical disease.
IV. SUMMARY AND FUTURE
DIRECTIONS
In this paper, we have shown the application of multi-
scale analysis to two types of intensive longitudinal bio-
medical signals, i.e., HRV and SPA time series. Recent
advances in wearable and/or biomedical sensing technol-
ogies [5]–[7] are enabling us to collect these data with
large temporal scales up to days and months during daily
life. Thus, it is now timely to start thinking about the rig-
orous “use” of this type of data. In particular, it is consid-
ered important to begin investigation into how to
robustly characterize their statistical and dynamical prop-
erties and how to practically utilize the analytical results
in medicine and healthcare.
It was shown that these ILD indeed have robust char-
acteristics unique to various multiscale complex systems,
and that some parameters for multiscale complexity are
in fact altered in pathological states, indicating potential
usability as new types of ambient diagnostic and/or prog-
nostic tools. For example, parameters characterizing in-
creased intermittency (like %s; Section II) of HRV are
found to be potentially useful in detecting abnormalities
in the state of the autonomic nervous system, in
Fig. 10. A bifurcation phenomenon of a bistable system and early warning signs for clinical phase transitions in bipolar disorder (BD).
(a) and (c): the potential landscapes for a depressive phase (a) and a manic phase (c). (b) is an illustration of a potential function at
the bifurcation point (e.g. saddle node bifurcation). When the control parameter of the system is sufficiently close to the bifurcation
point, the steady states become unstable and the most unstable direction in phase space dominates the behavior of the system. This
direction is determined by the eigenvector of the Jacovian corresponding to the eigenvalue for which the eigenvalue becomes zero
real valued. Around this point, fluctuations with unique dynamical properties (e.g., critical slowing down) can be observed. (d) The
fluctuations in $ around the period of the phase transition from depression to mania. (e) The alteration in autocorrelation coefficients
obtained by fitting an autoregressive model of order 1 [AR(1) model] to the data of $ within a sliding window of size 10-days. The
locations where the values of autocorrelation coefficient approach to zero may correspond to the “stable” depressive and manic
phase [labeled “(a)” and “(b)”] as illustrated in panel (a) and (b), respectively.
particular overall sympathetic hyperactivity, and the in-
termittency of SPA (characterized by $; Section III)
might also be useful in evaluating symptoms in psychiat-
ric patients with depressive as well as manic episodes, all
in daily settings. Furthermore, increased deviations and
low frequency correlation appeared to be observed
around transition points of disease states, with a potential
application to disease forecasting, prevention, and control
under the concept of dynamical disease [33], [34].
In conclusion, multiscale analysis might be a useful
tool to extract information on clinical events occurring
on multiple time scales during daily life, and on the
underlying physiological control mechanisms from bio-
medical ILD. In the following, we put forward some
promising directions for future research:
1) Multiscale analysis of physiological signals: While
the multiscale analysis performed off-line on
high quality data have shown the ability to as-
sess the physiological status of subjects, the de-
velopments of a variety of wearable devices as
well as their massive use yield further changes
for analysis tools. First, low price devices may
have limited performance, with high rates of
missing data or strong quantizations. It is thus
important to develop robust methodology against
such crucial issues. Second, the explosion of data
size would eventually make a posteriori off-line
processing impossible. Thus, further develop-
ment of multicale analysis algorithms with low
memory and computational costs, and on-the-fly
architecture. Such an on-line architecture would
also play important roles for disease prevention
and control involving forecasting.
2) Validation and reliability tests of multiscale analysis
in clinical applications: HRV has been used to study
various pathological conditions, such as heart fail-
ure, coronary artery disease, arterial hypertension,
diabetes, stroke, etc. [64]. Despite the widespread
use and expected applications of HRV, studies re-
lated to its application in clinical medicine are still
very limited. To establish the physiological and
clinical significance of HRV, especially that based
on multiscale analysis of ILD for early prediction,
diagnosis, and risk assessment, extensive valida-
tions are needed. The same also applies to SPA
time series. To do this, a close collaboration be-
tween clinicians, biomedical physicists and engi-
neers is an important factor [154].
3) Intensive longitudinal data and data mining: While
HRV and SPA are currently typical ILD, the de-
velopment of wearable and/or biomedical sensing
technologies, the prevalence of high-speed Inter-
net access and low-cost data storage have now
made it possible to collect various types of mas-
sive biomedical ILD. The application of the multi-
scale analysis introduced here to a variety of this
“bio-big data” including, e.g., blood pressure, glu-
cose, and symptom diaries, will also be important
for health-related applications. Also, feature selec-
tion and machine learning approaches [155],
which provide different information compared to
assessment by multiscale and conventional analy-
sis, might be promising [156]. The optimal choice
of these approaches would contribute to extract
important bio-markers for early prediction, diag-
nosis and risk assessment of diseases.
4) Multiscale mechanisms of dynamical disease: Mas-
sive biomedical ILD and extracted disease spe-
cific bio-markers can be used to gain insights
into the dynamical systems underlying patholog-
ical transitions and/or pathogenesis of diseases,
enabling elucidation of their mathematical
models based on concepts of nonlinear dynamics
such as multi-stability and bifurcation of attrac-
tors. These approaches would lead to the meth-
odological developments for early detection of
disease onset and exacerbation based on analysis
of biomedical ILD measured in daily life. The
early detection or prediction of pathological
transitions enables control of the risk of disease
and significantly contributes to effective health-
care management and disease prevention. h
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